| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 31,754 | 28,465 | 28,870 | 29,591 | | Cost of Revenue | 7,113 | 6,359 | 5,902 | 6,589 | | | Gross Profit | 24,641 | 22,106 | 22,968 | 23,002 | | | Operating Expenses | | Research Development | 4,110 | 3,927 | 4,451 | 4,574 | | Selling General and Administrative | 12,954 | 11,574 | 12,384 | 12,523 | | Non Recurring |
-
|
-
|
-
| 47,945 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,577 | 6,605 | 6,133 | (42,040) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 218 | 35 | 148 | 203 | | Earnings Before Interest And Taxes | 7,795 | 6,640 | 6,281 | (41,837) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 7,795 | 6,640 | 6,281 | (41,837) | | Income Tax Expense | 2,590 | 2,510 | 2,374 | 1,126 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,205 | 4,130 | 3,907 | (42,963) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,205 | 4,130 | 3,907 | (42,963) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,205 | $4,130 | $3,907 | ($42,963) |
|
1.23% Nasdaq 
Income Statement
